ArticlePharmaceuticals (Basel, Switzerland)2022

Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment.

Sahar Eljack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.